|
541 |
Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis
Enthalten in Clinical drug investigation Bd. 30, 24.8.2012, Nr. 10, date:10.2010: 675-685
|
|
|
|
542 |
Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma
Enthalten in Clinical drug investigation Bd. 32, 29.8.2012, Nr. 1, date:1.2012: 51-61
|
|
|
|
543 |
Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects
Enthalten in Pediatric drugs Bd. 14, 31.8.2012, Nr. 2, date:4.2012: 119-130
|
|
|
|
544 |
Safety and Tolerability of the Switch from Buprenorphine to Buprenorphine/Naloxone in an Italian Addiction Treatment Centre
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 27-31
|
|
|
|
545 |
Safety-Related Regulatory Actions for Orphan Drugs in the US and EU
Enthalten in Drug safety Bd. 33, 19.10.2012, Nr. 2, date:2.2010: 127-137
|
|
|
|
546 |
Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer’s Disease
Enthalten in Clinical drug investigation Bd. 29, 17.9.2012, Nr. 11, date:11.2009: 729-738
|
|
|
|
547 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Fimasartan Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects
Enthalten in American journal of cardiovascular drugs Bd. 11, 17.8.2012, Nr. 5, date:10.2011: 335-346
|
|
|
|
548 |
Science and Medicine Applied to Soccer Refereeing
Enthalten in Sports medicine Bd. 42, 23.12.2012, Nr. 7, date:7.2012: 615-631
|
|
|
|
549 |
Seasonal Influenza Vaccination of Healthy Working-Age Adults
Enthalten in Drugs Bd. 72, 22.11.2012, Nr. 1, date:1.2012: 35-48
|
|
|
|
550 |
Secondary Amyloidosis in a Patient with Long Duration Crohn's Disease Treated with Infliximab
Enthalten in BioDrugs Bd. 24, 16.8.2012, Nr. 1, date:12.2010: 15-17
|
|
Administration
